A Study of the Relative Bioavailability of a New Formulation of BCX4161 and the Effect of Food on BCX4161

NCT02125162 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Hereditary Angioedema

Interventions

DRUG: BCX4161

Sponsor

BioCryst Pharmaceuticals